BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bernardi D, Podswiadek M, Zaninotto M, Punzi L, Plebani M. YKL-40 as a marker of joint involvement in inflammatory bowel disease. Clin Chem. 2003;49:1685-1688. [PMID: 14500601 DOI: 10.1373/49.10.1685] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Ngernyuang N, Shao R, Suwannarurk K, Limpaiboon T. Chitinase 3 like 1 (CHI3L1) promotes vasculogenic mimicry formation in cervical cancer. Pathology 2018;50:293-7. [PMID: 29452694 DOI: 10.1016/j.pathol.2017.09.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
2 Di Rosa M, Distefano G, Zorena K, Malaguarnera L. Chitinases and immunity: Ancestral molecules with new functions. Immunobiology 2016;221:399-411. [PMID: 26686909 DOI: 10.1016/j.imbio.2015.11.014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 8.5] [Reference Citation Analysis]
3 Ngernyuang N, Francescone RA, Jearanaikoon P, Daduang J, Supoken A, Yan W, Shao R, Limpaiboon T. Chitinase 3 like 1 is associated with tumor angiogenesis in cervical cancer. Int J Biochem Cell Biol 2014;51:45-52. [PMID: 24691276 DOI: 10.1016/j.biocel.2014.03.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
4 Kzhyshkowska J, Gratchev A, Goerdt S. Human Chitinases and Chitinase-Like Proteins as Indicators for Inflammation and Cancer. Biomark�Insights 2007;2:117727190700200. [DOI: 10.1177/117727190700200023] [Cited by in Crossref: 115] [Cited by in F6Publishing: 51] [Article Influence: 28.8] [Reference Citation Analysis]
5 Salomon J, Matusiak Ł, Nowicka-Suszko D, Szepietowski JC. Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis. Mediators Inflamm 2017;2017:9538451. [PMID: 28932021 DOI: 10.1155/2017/9538451] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
6 Salomon J, Matusiak Ł, Nowicka-Suszko D, Szepietowski JC. Chitinase-3-like protein 1 (YKL-40) is a biomarker of severity of joint involvement in psoriatic arthritis. Postepy Dermatol Alergol 2018;35:485-9. [PMID: 30429706 DOI: 10.5114/ada.2018.77239] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
7 Ohno M, Bauer PO, Kida Y, Sakaguchi M, Sugahara Y, Oyama F. Quantitative Real-Time PCR Analysis of YKL-40 and Its Comparison with Mammalian Chitinase mRNAs in Normal Human Tissues Using a Single Standard DNA. Int J Mol Sci 2015;16:9922-35. [PMID: 25941933 DOI: 10.3390/ijms16059922] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
8 Maddens B, Ghesquière B, Vanholder R, Demon D, Vanmassenhove J, Gevaert K, Meyer E. Chitinase-like proteins are candidate biomarkers for sepsis-induced acute kidney injury. Mol Cell Proteomics 2012;11:M111.013094. [PMID: 22233884 DOI: 10.1074/mcp.M111.013094] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
9 Kong Y, Zhang S, Su X, Peng D, Su Y. Serum levels of YKL-40 are increased in patients with psoriasis: a meta-analysis. Postgraduate Medicine 2019;131:405-12. [DOI: 10.1080/00325481.2019.1643634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Di Rosa M, Brundo VM, Malaguarnera L. New insights on chitinases immunologic activities. World J Immunol 2016; 6(2): 96-104 [DOI: 10.5411/wji.v6.i2.96] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
11 Pan JJ, Ge YS, Xu GL, Jia WD, Liu WF, Li JS, Liu WB. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2013;139:1043-1054. [PMID: 23525579 DOI: 10.1007/s00432-013-1415-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
12 Mazur M, Zielińska A, Grzybowski MM, Olczak J, Fichna J. Chitinases and Chitinase-Like Proteins as Therapeutic Targets in Inflammatory Diseases, with a Special Focus on Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:6966. [PMID: 34203467 DOI: 10.3390/ijms22136966] [Reference Citation Analysis]
13 Benfaremo D, Luchetti MM, Gabrielli A. Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs. J Immunol Res 2019;2019:8630871. [PMID: 31276001 DOI: 10.1155/2019/8630871] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Jensen P, Wiell C, Milting K, Poggenborg R, Østergaard M, Johansen J, Skov L. Plasma YKL-40: a potential biomarker for psoriatic arthritis?: Plasma YKL-40 in psoriasis and psoriatic arthritis. Journal of the European Academy of Dermatology and Venereology 2013;27:815-9. [DOI: 10.1111/j.1468-3083.2012.04570.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
15 Ahmed SF, Attia EA, Saad AA, Sharara M, Fawzy H, El Nahrery EM. Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings. J Eur Acad Dermatol Venereol. 2015;29:682-688. [PMID: 25087779 DOI: 10.1111/jdv.12653] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
16 Erzin Y, Uzun H, Karatas A, Celik AF. Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn’s disease. J Gastroenterol Hepatol. 2008;23:e357-e362. [PMID: 17725598 DOI: 10.1111/j.1440-1746.2007.05121.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
17 Jiang Y, Zhang G, Wang Z, Yang H. Serum YKL-40 levels as a prognostic factor in patients with intracerebral hemorrhage. Clinical Biochemistry 2014;47:302-6. [DOI: 10.1016/j.clinbiochem.2014.09.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
18 Pizano-Martínez O, Yañez-Sánchez I, Alatorre-Carranza P, Miranda-Díaz A, Ortiz-Lazareno PC, García-Iglesias T, Daneri-Navarro A, Mercado MVD, Fafutis-Morris M, Delgado-Rizo V. YKL-40 expression in CD14+ liver cells in acute and chronic injury. World J Gastroenterol 2011; 17(33): 3830-3835 [PMID: 21987626 DOI: 10.3748/wjg.v17.i33.3830] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
19 Liton PB, Liu X, Stamer WD, Challa P, Epstein DL, Gonzalez P. Specific targeting of gene expression to a subset of human trabecular meshwork cells using the chitinase 3-like 1 promoter. Invest Ophthalmol Vis Sci 2005;46:183-90. [PMID: 15623772 DOI: 10.1167/iovs.04-0330] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
20 Ringsholt M, Høgdall EV, Johansen JS, Price PA, Christensen LH. YKL-40 protein expression in normal adult human tissues--an immunohistochemical study. J Mol Histol 2007;38:33-43. [PMID: 17242979 DOI: 10.1007/s10735-006-9075-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 3.3] [Reference Citation Analysis]
21 Ohno M, Kida Y, Sakaguchi M, Sugahara Y, Oyama F. Establishment of a quantitative PCR system for discriminating chitinase-like proteins: catalytically inactive breast regression protein-39 and Ym1 are constitutive genes in mouse lung. BMC Mol Biol 2014;15:23. [PMID: 25294623 DOI: 10.1186/1471-2199-15-23] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
22 Ehlers MR, Leary ET. Biochemical Markers of Rheumatoid Arthritis and Osteoarthritis: Clinical Utility and Practical Considerations. In: Reid DM, Miller CG, editors. Clinical Trials in Rheumatoid Arthritis and Osteoarthritis. London: Springer; 2008. pp. 151-69. [DOI: 10.1007/978-1-84628-742-8_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]